Literature DB >> 15643556

Phosphodiesterase and thymidine phosphorylase-inhibiting salirepin derivatives from Symplocos racemosa.

Muhammad Athar Abbasi1, Viqar Uddin Ahmad, Muhammad Zubair, Naheed Fatima, Umar Farooq, Sajjad Hussain, Muhammad Arif Lodhi, M Iqbal Choudhary.   

Abstract

A re-investigation of the chemical constituents of the stem bark of Symplocos racemosa Roxb. led to the isolation of four new glycosides, symplocomoside (1), symponoside (2), symplososide (3) and symploveroside (4). Benzoylsalireposide (5) and salireposide (6) were re-isolated from this plant. The structures of the new compounds were determined by 1D and 2D-homonuclear and heteronuclear NMR spectroscopy, chemical evidence, and by comparison with the published data of the closely related compounds. The glycosides 1-4 displayed in vitro inhibitory activity against phosphodiesterase I with IC50 values of 122 +/- 0.017, 698 +/- 0.06, 722 +/- 0.03, 909 +/- 0.09 microM, respectively. The compounds 1-6 also showed in vitro inhibitory activity against thymidine phosphorylase with IC50 values of 189.96 +/- 1.02, 195.56 +/- 2.36, 207.61 +/- 1.06, 488.89 +/- 4.10, 427.20 +/- 5.36, 354.2 +/- 5.69 microM, respectively while 1 was also found to be a urease inhibitor with an IC50 value of 54.13 +/- 0.71 microM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15643556     DOI: 10.1055/s-2004-835850

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.

Authors:  Asenate A X Adrião; Aline O Dos Santos; Emilly J S P de Lima; Jéssica B Maciel; Weider H P Paz; Felipe M A da Silva; Manuela B Pucca; Ana M Moura-da-Silva; Wuelton M Monteiro; Marco A Sartim; Hector H F Koolen
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

2.  Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.

Authors:  Luena Papa; Eran Zimran; Mansour Djedaini; Yongchao Ge; Umut Ozbek; Robert Sebra; Stuart C Sealfon; Ronald Hoffman
Journal:  Blood Adv       Date:  2018-10-23

3.  Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro, kinetic, and in silico studies.

Authors:  Sumaira Javaid; Syed Muhammad Saad; Humaira Zafar; Rizwana Malik; Khalid Mohammed Khan; M Iqbal Choudhary; Atta-Ur Rahman
Journal:  PLoS One       Date:  2020-01-27       Impact factor: 3.240

4.  Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies.

Authors:  Sumaira Javaid; Muniza Shaikh; Narjis Fatima; M Iqbal Choudhary
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.